Major advances in clinical treatment of Parkinson′ s disease in 2024
10.3760/cma.j.cn113694-20250710-00406
- VernacularTitle:2024年帕金森病临床治疗进展
- Author:
Yixuan YIN
1
;
Tao WU
1
;
Tao FENG
1
Author Information
1. 首都医科大学附属北京天坛医院神经病学中心 运动障碍性疾病科，北京 100070
- Publication Type:Journal Article
- Keywords:
Parkinson disease;
Treatment;
Advances
- From:
Chinese Journal of Neurology
2025;58(11):1235-1240
- CountryChina
- Language:Chinese
-
Abstract:
In 2024, notable progress was made in the clinical treatment of Parkinson′s disease (PD). These advancements encompass key areas such as novel drugs like glucagon-like peptide-1 receptor agonists, pralidoxime, and levodopa subcutaneous injection, novel neuroregulatory therapies like closed-loop adaptive deep brain stimulation, bilateral magnetic resonance imaging-guided focused ultrasound ablation, and fecal microbiota transplantation, all of which have propelled the precision treatment of PD. The significant advancements in the clinical treatment of PD published in major international academic journals in 2024 were systematically reviewed in this article.
